Pharmaceutical drug patents enable branded drug companies to prevent market entry by competitors until the patents expire. The term of […]
Source
Dabigatran etexilate mesylate is the generic ingredient in two branded drugs marketed by Alkem Labs Ltd, Apotex, Hetero Labs Ltd […]
Source
New tentative approval for Alembic drug dabigatran etexilate mesylate Read Post »
OPANA ER (oxymorphone hydrochloride) Endo pharms Patent: 8,114,383 Expiration: Aug 8, 2024 See More … For more information on how […]
Source
Drug Patent Expirations for the Week of August 4, 2024 Read Post »
Dabigatran etexilate mesylate is the generic ingredient in two branded drugs marketed by Alkem Labs Ltd, Apotex, Hetero Labs Ltd […]
Source
New tentative approval for Alembic drug dabigatran etexilate mesylate Read Post »
This chart shows the pharmaceutical companies with the most patents in Bulgaria. Patents must be filed in each country (or, […]
Source
Which pharmaceutical companies have the most drug patents in Bulgaria? Read Post »
Annual Drug Patent Expirations for ACUVAIL Acuvail is a drug marketed by Abbvie and is included in one NDA. It […]
Source
Dabigatran etexilate mesylate is the generic ingredient in two branded drugs marketed by Alkem Labs Ltd, Apotex, Hetero Labs Ltd […]
Source
New tentative approval for Alembic drug dabigatran etexilate mesylate Read Post »
This chart shows the drugs with the most patents in Colombia. Patents must be filed in each country (or, in […]
Source
Which pharmaceutical drugs have the most drug patents in Colombia? Read Post »
Dabigatran etexilate mesylate is the generic ingredient in two branded drugs marketed by Alkem Labs Ltd, Apotex, Hetero Labs Ltd […]
Source
New tentative approval for Alembic drug dabigatran etexilate mesylate Read Post »
This chart shows the pharmaceutical companies with the most patents in Eurasian Patent Organization. Patents must be filed in each […]
Source